Jennifer Lazzara, APRN
Nurse Practitioner · Spokane Valley, WANPI 1720503881
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Myriad Genetic Laboratories, Inc. accounts for 74.4% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2023 at $4,042 and has fallen 61.1% since, to $1,572 in 2025. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $71.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$8K
- AstraZeneca$373
- Sanofi$285
- Tactile Systems Technology Inc$276
- Seagen Inc.$213
- Pfizer$196
- plus $2K from 25 others
What the payments were for
- Consulting fees$2,62523%
- Speaking & faculty fees$3,72533%
- Travel & lodging$4834%
- Food & beverage$4,22737%
- Education$2993%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 64 | $8,450 |
| AstraZeneca | 11 | $373 |
| Sanofi | 2 | $285 |
| Tactile Systems Technology Inc | 4 | $276 |
| Seagen Inc. | 3 | $213 |
| Pfizer | 11 | $196 |
| Novartis | 9 | $181 |
| Incyte Corporation | 4 | $161 |
| Koya Medical, Inc. | 1 | $108 |
| CTI Biopharma Corp. | 1 | $106 |
| E.r. Squibb & Sons, L.L.C. | 5 | $95 |
| Merck | 4 | $86 |
| Blueprint Medicines Corporation | 4 | $71 |
| Lilly USA, LLC | 3 | $70 |
| Astellas Pharma US Inc | 3 | $69 |
| Array Biopharma Inc | 3 | $68 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Johnson & Johnson | 3 | $64 |
| Genentech USA, Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| AbbVie | 2 | $43 |
| Bristol Myers Squibb | 2 | $36 |
| Puma Biotechnology, Inc. | 2 | $33 |
| Iovance Biotherapeutics, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Tersera Therapeutics LLC | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| Sobi, Inc | 1 | $22 |
| GSK | 1 | $20 |
| Pharmaand GmbH | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$6,464
- SARCLISA$285
- Koya Medical$217
- Dayspring$217
- PreciseTumor$175
- Flexitouch Plus$132
- ENTRE$132
- myChoice CDx$125
- LYNPARZA$121
- Vonjo$106
How this compares
$11,358 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 12 | $555 |
| Tamoxifen Citrate | 14 | $506 |
| Letrozole | 16 | $437 |
| Anastrozole | 25 | $338 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Spokane Valley
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
- Vicki HainesPasco$57K
- Jessica ArmitageSumner$46K
- Lia Duque Estrada de BarrosSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.